Candel Therapeutics, Inc. CADL Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s interest coverage?
- Candel Therapeutics, Inc. (CADL) reported interest coverage of -16.7× in Q1 2026.
- How has Candel Therapeutics, Inc.'s interest coverage changed year-over-year?
- Candel Therapeutics, Inc.'s interest coverage increased by 13.0% year-over-year, from -19.2× to -16.7×.
- What is the long-term trend for Candel Therapeutics, Inc.'s interest coverage?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s interest coverage has grown at a 3.9% compound annual growth rate (CAGR), from -20.3× to -22.8×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.